Radius Health Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for RADIUS HEALTH INC, and when can generic versions of RADIUS HEALTH INC drugs launch?
RADIUS HEALTH INC has one approved drug.
There are five US patents protecting RADIUS HEALTH INC drugs.
There are forty-three patent family members on RADIUS HEALTH INC drugs in twenty-six countries.
Summary for Radius Health Inc
International Patents: | 43 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Radius Health Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Radius Health Inc | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 8,748,382 | See Plans and Pricing | See Plans and Pricing | ||||
Radius Health Inc | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 8,148,333 | See Plans and Pricing | Y | See Plans and Pricing | |||
Radius Health Inc | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 10,996,208 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Radius Health Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2637283 | See Plans and Pricing |
South Korea | 101512377 | See Plans and Pricing |
South Korea | 20170067906 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.